HHS Hands FDA Responsibility for ClinicalTrials.gov Accuracy

The FDA will begin policing compliance with clinical trial submission requirements for ClinicalTrials.gov under a policy change at HHS. Previously, HHS verified the completeness and accuracy of the information on the site. A Wednesday Federal Register notice states the responsibility has now transferred to FDA, and it charges the agency with identifying incorrect or fraudulent submissions and seeking out unsubmitted trial results.
Washington Drug Letter